drugset / Trial / NCT02715648

Using Phenazopyridine for In-office Cystoscopy

NCT02715648

Unknown 94 enrolled Boston Urogynecology Associates
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The investigators propose to conduct a randomized controlled trial to evaluate whether administration of phenazopyridine prior to the procedure decreases office cystoscopy time. Women undergoing in-office cystoscopy at Boston Urogynecology will be recruited.

Timeline

Start
2016-04-01
Primary completion
2021-06-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenazopyridine Small molecule 200 mg Oral

Indications

No indication recorded.